[
    [
        {
            "time": "2020-01-01",
            "original_text": "医药新股大盘点 谁最强？",
            "features": {
                "keywords": [
                    "医药",
                    "新股",
                    "大盘"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药新股大盘点 谁最强？",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-07-01",
            "original_text": "甘李药业：收到印尼药监局签发的门冬胰岛素原料药注册批件",
            "features": {
                "keywords": [
                    "甘李药业",
                    "印尼",
                    "门冬胰岛素",
                    "原料药",
                    "注册批件"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业：收到印尼药监局签发的门冬胰岛素原料药注册批件",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-07-02",
            "original_text": "甘李药业(603087.SH)：门冬胰岛素获得印度尼西亚原料药注册批件",
            "features": {
                "keywords": [
                    "甘李药业",
                    "门冬胰岛素",
                    "印度尼西亚",
                    "原料药",
                    "注册批件"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业(603087.SH)：门冬胰岛素获得印度尼西亚原料药注册批件",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]